Abstract: Although widely used, the Hamilton Rating Scale for Depression (HRSD) and Hamilton Anxiety Rating Scale (HARS) discriminate poorly between depression and anxiety. To address this problem, Riskind, Beck, Brown, and Steer (J Nerv Ment Dis. 175:474-479, 1987) created the Reconstructed Hamilton Scales by reconfiguring HRSD and HARS items into modified scales. To further analyze the reconstructed scales, we examined their factor structure and criterion-related validity in a sample of patients with major depressive disorder and no comorbid anxiety disorders (n = 215) or with panic disorder and no comorbid mood disorders (n = 149). Factor analysis results were largely consistent with those of Riskind et al. The correlation between the new reconstructed scales was small. Compared with the original scales, the new reconstructed scales correlated more strongly with diagnosis in the expected direction. The findings recommend the use of the reconstructed HRSD over the original HRSD but highlight problems with the criterion-related validity of the original and reconstructed HARS.
T he Hamilton Rating Scale for Depression (HRSD; Hamilton, 1960) and the Hamilton Anxiety Rating Scale (HARS; Hamilton, 1959) are widely used measures of depression and anxiety. The HRSD is considered to be the gold standard measure of depression and is frequently used as an outcome measure in depression treatment trials. Despite their wide usage, the HRSD and the HARS have been criticized on a number of grounds. Specifically, researchers have questioned the content validity of these scales: HRSD items capture many symptoms thought to be characteristic of anxiety but not depression, and HARS items capture symptoms thought to be characteristic of depression but not anxiety (Bagby et al., 2004; Maier et al., 1988) . Further, researchers have noted that HRSD and HARS fail to capture important aspects of depression and anxiety, respectively. For example, the widely used 17-item version of the HRSD does not assess worthlessness or concentration difficulties, even though these symptoms are included in the diagnostic criteria for major depressive disorder (MDD; Bagby et al., 2004) , and the HARS has been criticized for not adequately measuring worry, a key feature of anxiety (Koerner et al., 2010) . Empirical research has also raised questions about the criterion-related validity of the scales: one study found the HARS failed to effectively distinguish between anxious and depressed individuals (Mountjoy and Roth, 1982) .
In response to some of these criticisms, Riskind et al. (1987) reconfigured the existing HRSD and HARS items to improve the scales' discrimination between depression and anxiety. By and large, the Reconstructed Hamilton Scales (HRSD-R and HARS-R) were empirically derived on the basis of the results of discriminant analyses and principal components analysis performed on a sample of 60 patients with Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III) MDD (American Psychiatric Association [APA], 1980) and no comorbid anxiety disorder diagnoses and 60 patients with generalized anxiety disorder (GAD) and no comorbid depressive disorder diagnoses. The reconstructed scales proved equivalent or superior to the original scales in internal consistency (α = .73 for both the original and revised HRSD and α = .83 for the HARS-R vs. α = .78 for the HARS) and superior to the original scales in criterionrelated validity, as measured by point-biserial correlations with diagnosis and discriminant function analyses. The latter results were replicated in a cross-validation sample of 38 patients with MDD and 33 patients with GAD. Further, the correlation between the reconstructed scales (r = 0.15) was much lower than the correlation between the original scales (r = 0.62), although the authors did not statistically test the difference in correlations.
A number of investigators have utilized the Reconstructed Hamilton Scales in their research: a search conducted using PsycINFO indicated that the article by Riskind et al. (1987) had been cited 154 times. Unfortunately, efforts to replicate the findings of Riskind et al. regarding the superior psychometric properties of the Reconstructed Hamilton Scales have been few and have been met with mixed success. Moras et al. (1992) examined the psychometric properties of the original and reconstructed scales in a sample of 412 outpatients with primary DSM-III-R anxiety disorder diagnoses (APA, 1987) . Of these, 285 had a comorbid diagnosis of MDD. Although the correlation between the reconstructed scales was lower than that of the original scales, suggesting improved discriminant validity, the correlation between the HRSD-R and HARS-R (r = 0.62) was substantially larger than that found by Riskind et al. in their cross-validation sample. Further, the reconstructed scales were not superior to the original scales in distinguishing anxious individuals with MDD from anxious individuals without a comorbid MDD diagnosis. Similarly, Diefenbach et al. (2001) examined the properties of the original and reconstructed scales in 82 older adults who met DSM-IV criteria for GAD (APA, 1994) , 36 of whom also met criteria for a comorbid depressive disorder diagnosis. Like Moras et al. (1992) , Diefenbach and colleagues found that the correlation between the revised scales (r = 0.58) was lower than that of the original scales but remained much larger than the correlation found by Riskind et al. (1987) in their cross-validation sample. Discriminant analysis indicated only a modest improvement for the reconstructed over the original scales in the correct classification of the GAD-only versus comorbid groups.
Several limitations of the present literature on the psychometric properties of the Reconstructed Hamilton Scales are readily apparent. First, apart from Riskind et al. (1987) , no one has examined the extent to which the reconstructed scales differentiate between individuals with depression and no comorbid anxiety disorder diagnoses and those with an anxiety disorder and no comorbid mood disorder diagnoses. Rather, Diefenbach et al. (2001) and Moras et al. (1992) both tested the extent to which the HARS-R and HRSD-R distinguished between individuals with anxiety disorders with no comorbid depressive disorders versus those with anxiety disorders and a depressive disorder. This is an important issue to ultimately investigate, but it is first important to test the replicability of the basic finding of Riskind et al. that the reconstructed scales successfully distinguish between depressive disorder without anxiety disorder and anxiety disorder without depressive disorder. Although depression and anxiety are overlapping constructs (Watson et al., 1988) and often co-occur (Kessler et al., 2005) , optimal measures of these constructs should capture the extent to which a given patient is depressed, independent of that patient's anxiety level, to the extent possible, and vice versa. Such measures will be most useful for researchers and clinicians alike. It is to be expected that differentiating between anxiety with and without depression may be quite a bit more challenging than distinguishing between cases without comorbidity given that the diagnostic picture may be less clear in comorbid populations. Second, the sample population was limited to older adults in one of these two studies. Previous research has suggested that depression may manifest differently in older adults (Blazer et al., 1986) and that it may be more difficult to distinguish anxiety from depression in this population (Parmelee et al., 1993) . Finally, although the factor analyses of Riskind et al. were conducted on a relatively small sample of participants, no research to date has investigated their obtained factor structure of the Hamilton scales in an independent sample. This is particularly important because item scores on the Hamilton scales are ordinal, not continuous, and traditional methods of factor analysis may yield biased estimates when indicators are not continuous (Kline, 2013) . More appropriate factor analytic methods have been developed for ordinal data since the publication of Riskind et al.'s article.
Given continued widespread use of the Hamilton scales, the reconstructed scales offer the potential for improving the validity of research in depression and anxiety. Thus, further examination of the psychometric properties of the reconstructed scales is important. In the present study, we test the factor structure and discriminant and criterion-related validity of the reconstructed scales in a sample of individuals with MDD and no comorbid anxiety disorder diagnoses and individuals with panic disorder (PD) and no comorbid mood disorder diagnoses. Participants included in the present sample were adults spanning a wide age range. A weighted least squares mean and variance (WLSMV)-adjusted estimator, which is appropriate for ordinal level data (Wirth and Edwards, 2007) , was utilized in factor analyses.
METHODS

Participants
The present sample consisted of 215 patients with MDD and 149 patients with PD, as defined by DSM-IV criteria (APA, 1994) . This study was conducted with the approval of the Institutional Review Board of the University of Pennsylvania.
Sample With MDD
Patients with MDD completed baseline measures for one of two trials comparing psychotherapy, pharmacotherapy, and placebo (Barber et al., 2012; DeRubeis et al., 2005) . In addition to a current primary diagnosis of MDD, patients were required to have a 17-item HRSD score higher than 13 in the Barber et al. trial (n = 70) and higher than 19 in the DeRubeis et al. trial (n = 145). Both trials excluded individuals with serious medical conditions and those with a history of schizophrenia or psychosis, and those deemed to be at high risk for suicide. These studies were approved by the Institutional Review Boards of the University of Pennsylvania and of Vanderbilt University. Patients with MDD with a current comorbid anxiety disorder diagnosis were included in the parent studies but excluded from this psychometric study; 55% of patients in the Barber et al. trial and 40% of patients in the DeRubeis et al. trial were excluded from the present sample because of comorbidity.
Sample With PD
Patients with PD completed baseline measures for a study comparing the efficacy of three forms of psychotherapy for PD (Milrod et al., 2016) . To meet criteria for the PD trial, patients were required to have a current primary diagnosis of PD with or without agoraphobia and to have had at least one panic attack per week in the month before study entry, unless they were avoiding most panicinducing situations due to agoraphobia. Actively suicidal patients and those with a history of psychosis or substance dependence within the past 6 months were excluded from the trial. This study was approved by the Institutional Review Boards of the University of Pennsylvania and of Weill Cornell Medical College. Patients with PD with a current comorbid mood disorder diagnosis were included in the parent study but excluded from this psychometric study; 26% of patients in the PD trial were excluded from the present sample because of comorbid mood disorders. However, the present sample includes patients with PD with comorbid DSM-IV anxiety disorder diagnoses (61.7% of the sample had ≥1 comorbid anxiety diagnosis).
Measures
Participants provided basic demographic information (Table 1) and gave written informed consent for the parent studies. All measures relevant to the present study were administered at intake by master'sand doctoral-level psychologists.
Structured Clinical Interview for DSM-IVAxis I Disorders
The Structured Clinical Interview for DSM-IV Axis I Disorders (First et al., 1995) was used to assess Axis I diagnoses in the samples with MDD. Interrater reliability was excellent (Cicchetti and Sparrow, 1981) comprising the present data set, the HRSD was administered in accordance with Williams' (1988) guide with some minor revisions to item 13 (described below). It should be noted that the content of HRSD items 12 and 13 differs slightly between Guy's and Williams' versions of the scale. Item 12 (called "somatic: gastrointestinal" on Guy's version of the scale and "appetite" on Williams' version of the scale) includes questions about feelings of heaviness in the abdomen and constipation on Guy's, but not the Williams', version of the scale. In addition, Guy's item 13 (called "somatic: general" on his version of the scale and "energy" on the version of the HRSD used in the current study) includes questions about head-, back-, and muscle aches that were removed from the version of the HRSD used in the present study. Apart from these changes, the two versions of the HRSD assess the same content.
Each HRSD item is rated on a 3-point or 5-point ordinal scale. Both 17-item and 24-item HRSD totals were calculated for the present study. Possible scores range from 0 to 52 on the 17-item HRSD and from 0 to 76 on the 24-item HRSD. Interrater reliability was excellent in all three study samples (r I = 0.80-0.96).
Hamilton Anxiety Rating Scale
The HARS is a 14-item measure originally designed to be administered as a semistructured interview (Hamilton, 1959) . The DeRubeis et al. (2005) MDD study utilized the original, semistructured HARS, whereas the PD study and the Barber et al. (2012) MDD study utilized a structured interview version of the HARS, which has been shown to have superior interrater reliability compared with the original measure (Bruss et al., 1994) . On both versions of the HARS, each symptom is rated on a 0 to 4 ordinal scale, with total possible HARS scores ranging from 0 to 56. Interrater reliability on the HARS was not calculated for either MDD study, as this was not a primary outcome measure. For the PD study, interrater reliability was excellent (r I = 0.96).
Analytical Approach
We first used exploratory factor analysis (EFA) to examine the factor structure of the Hamilton scales in our sample. We used this approach rather than confirmatory factor analysis (CFA) because of slight differences in item content between the version of the Hamilton scales we utilized and the version used by Riskind et al. (1987) , and because CFA may yield a poor model fit when item-level data are used as indicators (Floyd and Widaman, 1995) . Because parallel analysis does not work well for categorical data, we examined scree plots to determine the number of factors to retain. On the basis of the results of the EFA, we made slight modifications to the Reconstructed Hamilton Scales. Because we lacked the sample size to replicate our factor structure in an independent sample, we adopted a conservative approach to modifying the reconstructed scales: we sought to remain as consistent with Riskind et al. as possible without discounting our empirical findings. Next, we examined the internal consistency of our modified scales (entitled the HRSD-R-II and HARS-R-II), and the correlation between the two scales and the point-biserial correlations between the respective scales and diagnosis (MDD or PD). We used Cohen's (1988) guidelines to interpret the magnitude of these correlations. We also compared the size of the correlations between the two scales and between each scale and diagnosis for the original HRSD and HARS and for the HRSD-R-II and HARS-R-II to determine whether our reconstructed scales demonstrated superior discriminant and criterion-related validity compared with the original scales. Finally, we examined the receiver operating characteristic (ROC) curves for the original and revised scales and compared the areas under the curve (AUCs) for the original and revised depression and anxiety scales, respectively, as a further test of whether our reconstructed scales demonstrated superior discriminant and criterion-related validity compared with the original scales.
RESULTS AND DISCUSSION
See Table 1 for demographic variables and median HRSD and HARS scores.
Factor Analysis
We first conducted an exploratory item-level factor analysis with all HARS and 24-item HRSD items as indicators to determine whether the two-factor solution generated would produce depression and anxiety factors roughly corresponding to those found by Riskind et al. (1987) . This analysis was conducted in MPlus using the categorical option and a WLSMV-adjusted estimator. The WLSMV makes use of the polychoric correlation matrix and assumes that categorical ordered responses reflect an underlying, continuous, multivariate normal response distribution (Wirth and Edwards, 2007) . This analysis was conducted using a Geomin (oblique) rotation and allowing for one-to five-factor solutions to explore other factor solutions that might provide a better fit for the data. Eigenvalues for the five factors were as follows: 8.22, 4.34, 2.32, 1.95, and 1.49. The two-factor solution closely matched the factor structure found by Riskind et al., producing factors corresponding to depression and anxiety, which were correlated at r = 0.05. An examination of the scree plot indicated that a threefactor solution provided the best fit to the data. This factor solution produced an anxiety factor identical to that found in the two-factor solution but further subdivided depression items into two factors representing vegetative and cognitive aspects of depression, respectively, with most depression items loading strongly on both depression factors but few anxiety items with secondary loadings on the depression factors and vice versa. There was a medium-sized and significant positive correlation between the two depression factors (r = 0.32, p < 0.05), and a small negative correlation between the anxiety factor and both depression factors (r = −0.20 with both depression factors, both p < 0.05). Combining the items from the two depression factors in the three-factor solution yielded a larger depression component virtually identical to that generated in the two-factor solution. Given that our goal was to validate reconstructed versions of the Hamilton scales that best distinguished between depression and anxiety, rather than to examine subfactors of depression, we chose to combine the two depression subfactors into a larger depression component for the purpose of assigning items to reconstructed depression or anxiety scales. Factor loadings for the three-factor solution, as well as item medians and ranges, are shown in Table 2 .
Although the three-factor solution generated with the present data was similar to the factor solution of Riskind et al. (1987) when the two depression subfactors were combined, several key differences emerged. Some of these seemed to reflect genuine differences in the response characteristics of our sample compared with those of Riskind et al.'s sample, whereas others seemed to be better attributed to the slight variations in item content between the version of the HRSD used in our study and the version used in Riskind et al.'s study. We detected three main differences in factor loadings for items whose content was unchanged between the different versions of the HRSD. First, Riskind et al. found that HARS item 12 (genitourinary) loaded comparably on depression and anxiety, and for this and other reasons, they excluded this item from the reconstructed scales. In contrast, we found that HARS item 12 loaded more strongly on the vegetative depression subfactor. Second, Riskind et al. found that HRSD item 9 (agitation) loaded more strongly on the anxiety factor. In our sample, this item failed to load strongly on any factor, although the loading was somewhat higher on the cognitive depression subfactor than the anxiety factor. Agitation was rarely observed in our sample, restricting the range on this variable for psychometric analysis. For this reason, we opted to stay consistent with Riskind et al. and kept agitation on the anxiety factor. Third, Riskind et al. found the HARS item 14 (behavior at interview) loaded more strongly on the anxiety factor, whereas we found that this item had comparable loadings on the anxiety factor and cognitive depression subfactor. To be conservative, we chose to remain consistent with Riskind et al. and to keep this item on the anxiety scale. Finally, Riskind et al. included HRSD items 4 (insomnia early) and 16 (weight loss) on the HRSD-R, despite the fact that they found that the former loaded more strongly on anxiety and the latter did not load strongly on either factor; in contrast, we found both items to load strongly on the depression factors and not the anxiety factor. Two main differences between our factor solution and the factor structure found by Riskind et al. (1987) seemed to be due directly to differences in HRSD item content. First, Riskind et al. found that HRSD item 12 (called somatic: gastrointestinal on their version of the scale) loaded on the anxiety factor; in contrast, we found that this item, called appetite on our version of the scale, loaded on the vegetative depression subfactor. Second, Riskind et al. found that HRSD item 13 (somatic: general on Guy's HRSD) loaded on the anxiety factor; in contrast, we found this item (energy on our version of the HRSD) to load on the depression factors. Riskind et al. chose to exclude this item from the reconstructed scales, despite its high loading on anxiety, because "it confounds headaches and backaches (aspects of anxiety) with heaviness in the back and limbs (usually an aspect of depression)" (p. 477). As noted, item content differed slightly for items 12 and 13 between our version of the HRSD and the version used by Riskind et al. such that questions about head-, back-, and muscle aches were removed from item 13 in the version of the HRSD used in the present study.
To summarize, when the two depression subfactors were combined, the three-factor solution generated by our EFA closely matched the factor structure reported by Riskind et al. (1987) , with a few minor differences that seemed to be by and large the result of slight differences in item wording between our version of the HRSD and the version used by Riskind et al. The similarity is remarkable given differences in the two study populations and in the factor analytic methods employed.
Final Revised Scales (HRSD-R-II and HARS-R-II)
Because we were unable to cross-validate the results of our EFA in an independent sample, we were wary of capitalizing on random variance that may have affected our results and therefore chose to largely retain Riskind et al.'s (1987) reconstructed scales in the remaining analyses, altering the configuration of the Reconstructed Hamilton Scales only when there was a very strong empirical or theoretical rationale for doing so. Given that HRSD items 12 and 13 differed both in item content and factor loading in our analyses compared with Riskind et al.'s analyses, we chose to remove HRSD item 12 from the reconstructed HARS and to include both HRSD items 12 and 13 on the reconstructed HRSD. In addition, we chose to include HRSD item 14 (genital on Guy's [1976] scale, libido on our version of the scale) on the Despite a significant loading on the depression factor, this item was excluded from the HRSD-R-II in an effort to remain consistent with Riskind et al.'s (1987) findings. b Agitation was rarely observed in our sample, restricting the range on this variable for psychometric analysis. Therefore, despite a slightly higher loading on the depression factor as compared with the anxiety factor, this item was included in the HARS-R-II in an effort to remain consistent with Riskind et al.'s (1987) findings.
c Despite a significant loading on the anxiety factor, this item was excluded from the HARS-R-II in an effort to remain consistent with Riskind et al.'s (1987) findings. Despite a significant loading on the depression factor, this item was excluded from the HRSD-R-II because of redundancy with items already included on the HRSD-R-II. e Despite a significant loading on the depression factor and the anxiety factor, this item was included in the HARS-R-II in an effort to remain consistent with Riskind et al.'s (1987) findings.
reconstructed HRSD. Both we and Riskind et al. found this item to load on the depression factor, but Riskind et al. excluded this item from the reconstructed scales without providing a theoretical or empirical rationale for this decision. Scale item assignments are displayed in Table 2 . We refer to our scales as the HRSD-R-II and HARS-R-II to distinguish them from Riskind et al.'s HRSD-R and HARS-R.
Psychometric Evaluation of the HRSD-R-II and HARS-R-II
We then evaluated the psychometric properties of the HRSD-R-II and HARS-R-II and compared these estimates to estimates obtained using the original HRSD 17-and 24-item versions and the original HARS.
Internal Consistency
We assessed the internal consistency (Cronbach's alpha) of the HRSD-R-II and HARS-R-II and compared estimates for the reconstructed scales and the original scales. For the HRSD-R-II, α = .85 compared with α = .77 for the 17-item HRSD and α = .81 for the 24-item version. For the HARS-R-II, α = .75 compared with α = .68 for the original HARS. Thus, internal consistency of the reconstructed scales was acceptable, consistent with previous research (Diefenbach et al., 2001; Moras et al., 1992; Riskind et al., 1987) .
Correlation Between the Depression and Anxiety Scales
To test whether the HRSD-R-II and HARS-R-II distinguished the constructs of depression and anxiety, we correlated the two scores and compared these correlations to the correlations between the original versions of the scales. The correlation between HRSD-R-II and HARS-R-II scores was small and nonsignificant (r = 0.03, p = 0.60), whereas there was a large correlation between scores on the original scales (r = 0.49 and r = .50 for HARS with 17-item HRSD and 24-item HRSD, respectively, both p < 0.001). Implementation of the Raghunathan et al. (1996) procedure for comparing nonoverlapping correlated correlation coefficients indicated that the correlation between the revised scales was significantly smaller than the correlation between the HARS and both the 17-item HRSD (ZPF = 13.03, p < 0.001) and the 24-item HRSD (ZPF = 15.10, p < 0.001). This finding is consistent with results reported by other researchers (Diefenbach et al., 2001; Moras et al., 1992; Riskind et al., 1987) . However, the very small magnitude of the correlation between the revised scales is consistent with Riskind et al.'s, but diverges from Diefenbach et al.'s and Moras et al.'s, findings. Perhaps the reason for this discrepancy relates to differences in study populations: both we and Riskind et al. examined a sample of individuals with depression without comorbid anxiety and individuals with anxiety without comorbid depression, whereas other authors examined the properties of the reconstructed scales in comorbid samples (Diefenbach et al., 2001; Moras et al., 1992) . We would expect the distinction between depression and anxiety to be most evident when examining these constructs in a sample without overlap in conditions, and indeed, this is what the results show.
Nonetheless, both we and Riskind et al. (1987) found the correlation between scales to be lower than expected given the welldocumented common features of depression and anxiety (e.g., negative affectivity; Watson et al., 1988) . The correlation between the reconstructed scales may be artificially low in our sample because factor analyses conducted on this sample guided the development of the HRSD-R-II and HARS-R-II, but this explanation cannot account for the low correlation between the reconstructed scales found in Riskind et al.'s cross-validation sample. More likely, the low correlation between scales may reflect problems with content validity. The Hamilton scales lack items that specifically address perseverative thought processes (e.g., rumination, worry), which are important shared features of depression and anxiety. Inclusion of such items on the depression and anxiety scales, respectively, may lead to a more complete coverage of the constructs of depression and anxiety and an increase in the correlation between scales.
performance of the depression scales relative to the anxiety scales as indexed by their correlations with diagnosis and the AUCs may be artifactual: patients with MDD in the present sample were selected on the basis of receiving a certain minimum score on the HRSD, whereas patients with PD were not required to achieve any particular cutoff on the HARS. Indeed, when we restricted the sample with PD to those who scored higher than 14 on the HARS (the empirical cutoff score for moderate GAD; Matza et al., 2010) , we found higher correlations in the expected direction between anxiety scale scores and diagnosis (r pb = −0.29 for diagnosis and HARS, p < 0.001; r pb = −0.58 for diagnosis and HARS-R-II, p < 0.001) and greater AUCs for the anxiety scales (for HARS, AUC = 0.72, SE = 0.03, p < 0.001; for HARS-R-II, AUC = 0.90, SE = 0.02, p < 0.001) than those found in the full sample. However, in this subsample, the correlations between the depression scales and diagnosis remained substantially larger than those between the anxiety scales and diagnosis, and the AUCs for the depression scales remained somewhat larger than those of the anxiety scales, suggesting that the use of cutoff scores for the sample with MDD only cannot fully explain the superior performance of the depression scales in our sample. Details of these analyses are available on request.
Alternatively, these findings might reflect better content validity for the HRSD as compared with the HARS: the HARS has been criticized for its lack of items capturing worry and other core cognitive features of anxiety (Koerner et al., 2010) . In contrast, the HRSD captures the core depressive symptoms of depressed mood and anhedonia, and it has been modified to include core cognitive features of depression such as helplessness, hopelessness, and worthlessness. Thus, the 24-item HRSD seems to more fully capture the construct of depression than the HARS captures the construct of anxiety.
CONCLUSIONS
We examined the psychometric properties of the Reconstructed Hamilton Scales in a substantial clinical sample of individuals with MDD and no comorbid anxiety disorder diagnoses and individuals with PD and no comorbid mood disorder diagnoses. To our knowledge, no published study apart from Riskind et al. (1987) has undertaken this endeavor in a sample of individuals with depression without comorbid Although the HARS-R-II outperformed in original HARS in terms of its correlation with diagnosis in the expected direction, this correlation remained quite modest, suggesting that even in its reconfigured form, the HARS-R-II remains far from optimal as a measure of anxiety symptoms. The present study has limitations. First, interrater reliability on the HARS was not calculated for the trials from which our sample with MDD was drawn. Thus, we cannot be certain raters were being consistent in their scoring of the HARS for patients with MDD. Second, given our sample size, we were unable to confirm whether the factor structure generated by our EFA could be replicated in an independent sample. Such replication is highly desirable because we made several minor changes to Riskind et al.'s (1987) reconstructed scales. Future research demonstrating that this factor structure can be replicated in an independent sample would increase our confidence in these results. Finally, our anxious sample included participants with a primary diagnosis of only one type of anxiety disorder, PD. Given the somatic nature of PD and the fact that the HARS tends to emphasize the somatic, rather than the cognitive, aspects of anxiety, it is possible that the HARS items may have greater content validity for PD than for other anxiety disorder diagnoses. Thus, one concern is that the HARS might perform even worse in a sample with different anxiety disorder diagnoses. However, our concern is lessened for two reasons: first, Riskind et al. found results similar to ours in a sample of patients with GAD, and second, most PD patients in our sample (61.7%) met criteria for at least one additional anxiety disorder diagnosis.
In summary, together with Riskind et al.'s (1987) findings, the present study provides support for the superior psychometric properties of the Reconstructed Hamilton Scales relative to the original scales. Although there is a long tradition of using the original HRSD and HARS to capture depression and anxiety, respectively, the results of the present study suggest that this decision warrants reconsideration. Specifically, researchers and clinicians might consider using the HRSD-R-II in place of the original HRSD to obtain a purer measure of depression. In contrast, although the HARS-R-II constitutes an improvement over the original HARS, our results do not recommend the use of this or the original scale given the low correlation between both versions of the reconstructed HARS and PD diagnosis. The HARS has also been criticized for not including items capturing key aspects of anxiety such as worry (Koerner et al., 2010) , and this criticism also applies to the HARS-R-II because we did not add additional items to the scale. In contrast, we are less concerned about the content validity of the HRSD-R-II because the 24-item HRSD (from which most HRSD-R-II items were drawn) seems to more fully capture the core symptoms of depression. It should be noted that although the HRSD-R-II seems to be quite successful in distinguishing between cases of depression without comorbid anxiety and cases of anxiety without comorbid depression, it may be considerably more difficult to make the distinction between depression and anxiety in comorbid samples, as was the case for Diefenbach et al. (2001) and Moras et al. (1992) . Nevertheless, if the Hamilton scales are to be used, our findings argue for the selection of the HRSD-R-II and HARS-R-II over the original scales.
